Abstract:Background: Malaria is one of the most important infectious diseases in the world. The most severe form of malaria in humans is caused by Plasmodium falciparum. Malaria is a worldwide health problem, with 214 million new cases in 2015 and 438,000 deaths, most of which are in Africa. Therefore, there is an urgent need for novel, low-toxic, more specific inhibitors to find new antimalarial agents. A promising target for antimalarial drug design is falcipain-2, a cysteine protease from P. falciparum that has received considerable attention due to its key role in the life cycle of the parasite. Materials and Methods: Three-dimensional quantitative structure-activity relationship (3D-QSAR) models of 39 peptidyl vinyl sulfone cysteine protease inhibitors was constructed using Topomer CoMFA. Topomer Search was employed to virtually screen lead-like compounds in the ZINC database. Molecular docking was employed to further explore the binding requirements between the ligands and the receptor protein which included several hydrogen bonds between peptidyl vinyl sulfone cysteine protease inhibitors and active site residues. Results: The non-cross correlation coefficient (r 2 ), the interaction validation coefficient (q 2 ) and the external validation (r 2 pred ) were 0.902, 0.685 and 0.763, respectively. The results showed that the model not only had good estimation stability but also good prediction capability. 22 new molecules were obtained, whose predicted activity is higher than the template molecules. The results showed that the Topomer Search technology can be effectively applied to screen and design new peptidyl vinyl sulfone cysteine protease inhibitors. Molecular docking showed extensive interactions between peptidyl vinyl sulfone cysteine protease inhibitors and residues of LYS24, ASP21, LYS59, and ASP17 in the active site. Conclusion: : 39 peptidyl vinyl sulfone cysteine protease inhibitors were used in the 3D-QSAR study. Topomer CoMFA 3D-QSAR method was used to build the model, and the model was well predicted and statistically validated. The design of potent new inhibitors of cysteine protease can get useful insights from these results.

3D-QSAR Studies on Tripeptide Aldehyde Inhibitors of Proteasome Using CoMFA and CoMSIA Methods

3D-QSAR studies of boron-containing dipeptides as proteasome inhibitors with CoMFA and CoMSIA methods.

Structure-Based Design Of Tripeptide Derivatives Of α-Aminoalkylphosphonate Esters For Prostate-Specific Antigen Inhibition

Structure-activity relationships and molecular design of epoxyketone peptide proteasome inhibitors

Combined 3D-QSAR, Molecular Docking and Molecular Dynamics Study on Derivatives of Peptide Epoxyketone and Tyropeptin-Boronic Acid As Inhibitors Against the Β5 Subunit of Human 20S Proteasome

Covalent complexes of proteasome model with peptide aldehyde inhibitors MG132 and MG101: docking and molecular dynamics study

3 D-QSAR study on antimicrobial peptides by CoMFA method

In Silico Rational Design and Virtual Screening of Antixoidant Tripeptides Based on 3D-QSAR Modeling

3D-QSAR Study with Pharmacophore-Based Molecular Alignment of Hydroxamic Acid-Related Phosphinates That Are Aminopeptidase N Inhibitors.

3D-QSAR and Molecular Docking Studies of Hydroxamic Acids As Peptide Deformylase Inhibitors

A 3D-QSAR Study of Catechol-O-methyltransferase Inhibitors Using CoMFA and CoMSIA

Discovery of Novel Covalent Proteasome Inhibitors Through a Combination of Pharmacophore Screening, Covalent Docking, and Molecular Dynamics Simulations.

Molecular Docking,3D-QSAR,and Molecular Design of Boronic Acid Derivatives of Tyropeptin Inhibitors of 20S Proteasome

3D-QSAR studies of HDACs inhibitors using pharmacophore-based alignment.

3D-QSAR study on a series of Bcl-2 protein inhibitors using comparative molecular field analysis.

3D-QSAR Modeling of Phosphodiesterase-5 Inhibitors: Evaluation and Comparison of the Receptor- and Ligand-Based Alignments

Synthesis and SAR Study of Novel Peptide Aldehydes As Inhibitors of 20S Proteasome

Molecular simulation of a series of benzothiazole PI3Kα inhibitors: probing the relationship between structural features, anti-tumor potency and selectivity

3D-QSAR Analysis on ATR Protein Kinase Inhibitors Using CoMFA and CoMSIA.

Design, Synthesis and Biological Evaluation of Tripeptide Boronic Acid Proteasome Inhibitors

A QSAR Study of Peptidyl Vinyl Sulfone Cysteine Protease Inhibitors Using Topomer CoMFA and Molecular Docking